This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer.This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, preventive strategies in limiting the epidemic of hormonally related cancers, and new treatment approaches.This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, preventive strategies in limiting the epidemic of hormonally related cancers, and new treatment approaches.One third of human cancers have a hormonal basis. Breast cancer, the most common cancer of women, is increasing in many countries, as is prostate cancer, the second most common cancer of men. Concurrently, molecular biology has refined the definition of hormones to include the interaction between tumor cells and both locally and distantly secreted factors. This volume in the series Cancer: Clinical Science in Practice considers aspects of hormonal cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, strategies in limiting the epidemic of hormonally related cancers, and new treatment approaches.Contributor list; Part I. The Regulation of Cancer: 1. The type 1 growth factor receptor family, their ligands and their role in human cancers T. Rajkumar and W. J. Gullick; 2. The fibroblast growth factor family and their receptors Pita Enriquez Harris and John K. Heath; 3. The biological role of transforming growth factor beta in cancer development Bradley A. Arrick and Rik Derynck; 4. Bombesin and its receptor Michael J. Seckl and Enrique Rozengurt; 5. GlCI